The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison between S-1 monotherapy and S-1 plus cisplatin as postoperative chemotherapy after R0 resection for stage IV gastric cancer patients with oligometastasis: A multicenter retrospective study.
 
Koshi Kumagai
No Relationships to Disclose
 
Toshifumi Yamaguchi
No Relationships to Disclose
 
Atsuo Takashima
Speakers' Bureau - Chugai Pharma; Merck; Taiho Pharmaceutical; Takeda
Research Funding - LSK BioPharma; MSD; Takeda
 
Kengo Nagashima
Consulting or Advisory Role - Fujimoto; Senju Pharmaceutical
 
Yosuke Kano
No Relationships to Disclose
 
Masanori Terashima
Honoraria - Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst)
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Kazuhiro Nishikawa
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Lilly; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical; Taiho Pharmaceutical
 
Kazuaki Tanabe
No Relationships to Disclose
 
Gen Yunome
No Relationships to Disclose
 
Yasuyuki Kawachi
No Relationships to Disclose
 
Takanobu Yamada
No Relationships to Disclose
 
Hiroki Fukunaga
No Relationships to Disclose
 
Takahiro Kinoshita
Honoraria - Covidien; Ethicon; Lilly; Olympus; Taiho Pharmaceutical
 
Masaya Watanabe
No Relationships to Disclose
 
Hiroki Taniguchi
No Relationships to Disclose
 
Takeshi Sakamoto
No Relationships to Disclose
 
Koshiro Ishiyama
No Relationships to Disclose
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)